Driehaus Capital Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.8M | Sell |
933,890
-234,901
| -20% | -$10.3M | 0.33% | 103 |
|
|
2025
Q1 | $32M | Sell |
1,168,791
-221,581
| -16% | -$6.06M | 0.31% | 105 |
|
|
2024
Q4 | $55.9M | Buy |
1,390,372
+61,669
| +5% | +$2.48M | 0.46% | 74 |
|
|
2024
Q3 | $62.9M | Buy |
1,328,703
+1,105,290
| +495% | +$52.3M | 0.54% | 53 |
|
|
2024
Q2 | $6.67M | Buy |
+223,413
| New | +$6.67M | 0.06% | 246 |
|
|
2022
Q2 | – | Sell |
-199,244
| Closed | -$8.43M | – | 402 |
|
|
2022
Q1 | $8.43M | Sell |
199,244
-440,238
| -69% | -$18.6M | 0.1% | 254 |
|
|
2021
Q4 | $40.6M | Buy |
639,482
+56,290
| +10% | +$3.57M | 0.41% | 75 |
|
|
2021
Q3 | $34.3M | Buy |
583,192
+551,611
| +1,747% | +$32.4M | 0.41% | 73 |
|
|
2021
Q2 | $1.53M | Buy |
+31,581
| New | +$1.53M | 0.02% | 324 |
|